The gut microbiome, comprising countless bacteria and many other microorganisms, plays a central role in supporting human health by helping to regulate metabolism and hormone balance, as well as acting as a key component of the immune system. It also plays a key role in communication between the gastrointestinal tract and the brain. Recent study findings now show that the gut microbiome is also significant in relation to Alzheimer’s disease. A German research team has, through a study, identified a new way of detecting Alzheimer’s disease at an early stage in those affected. As part of the AlzBiom study, they examined the gut microbiome of 100 healthy older adults with no memory impairment, 100 people with mild memory impairment and 100 people with confirmed mild Alzheimer’s dementia. Using shotgun metagenomic sequencing – a method for sequencing and analysing long DNA strands – it was demonstrated for the first time that the gut microbiome of patients with Alzheimer’s differs significantly from that of healthy study participants, both at the species level (composition of bacterial species) and at the functional level (metabolic processes) from that of healthy study participants. Analysis of the microbiome allows for the accurate identification of people with Alzheimer’s disease, which underlines the diagnostic significance of the gut microbiome. Although there is currently no cure for the disease, the study results suggest that modulating the gut microbiome could represent a new, innovative approach to treating Alzheimer’s disease. Reference: University of Tübingen, TU Darmstadt ‘Signature of Alzheimer’s Disease in the Intestinal Microbiome: Results From the AlzBiom Study, Frontiers in Neuroscience 2022; https://www.frontiersin.org/articles/10.3389/fnins.2022.792996/full
Alzheimer’s and gut flora